Published in Cancer Weekly, August 22nd, 2006
According to a recent article published in the International Journal of Radiation Oncology Biology Physics, scientists in Switzerland conducted research "to assess the clinical profile, treatment outcome, and prognostic factors in PSEL. Between 1982 and 2002, 52 consecutive patients with PSEL were treated in 9 institutions of the Rare Cancer Network. Forty-eight patients had an Ann Arbor stage IE and 4 had a stage IIE."
"Forty-eight patients underwent decompressive laminectomy, all received RT with (n=32) or without...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.